Randomized Trial of Topotecan With M6620, an ATR Kinase Inhibitor, in Small Cell Lung Cancers and Small Cell Cancers Outside of the Lungs
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Hoffmann-La Roche
NeoImmuneTech
Hoffmann-La Roche
MacroGenics
AstraZeneca
Hoffmann-La Roche
Amgen
AstraZeneca
Shanghai Henlius Biotech
AstraZeneca
Washington University School of Medicine
National Cancer Institute (NCI)
AstraZeneca
National Cancer Institute (NCI)
Amgen
National Cancer Institute (NCI)
G1 Therapeutics, Inc.
G1 Therapeutics, Inc.
Hoffmann-La Roche
Incyte Corporation
University of Iowa
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)
NRG Oncology
NanOlogy, LLC
AstraZeneca
University of California, San Francisco
Hutchmed
Roswell Park Cancer Institute
National Institutes of Health Clinical Center (CC)